3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
21
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Myelodysplastic Syndromes
15
Multiple Myeloma
11
Recurrence
8
Ovarian Neoplasms
8
Lymphoma
7
Burkitt Lymphoma
7
Pancreatic Neoplasms
6
Lymphoma, Non-Hodgkin
6
Lymphoma, B-Cell
6
Hodgkin Disease
6
Colorectal Neoplasms
6
Myeloproliferative Disorders
5
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
5
Leukemia, Biphenotypic, Acute
5
Stomach Neoplasms
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Chronic
4
Leukemia
4
Hematologic Neoplasms
4
Carcinoma, Non-Small-Cell Lung
4
Urogenital Neoplasms
3
Triple Negative Breast Neoplasms
3
Sarcoma
3
Osteosarcoma
3
Melanoma
3
Lymphoma, Mantle-Cell
3
Lymphoma, Follicular
3
Leukemia, B-Cell
3
Interventions
tocilizumab
1
siltuximab
1
obinutuzumab
1
glofitamab
1
Oxaliplatin
1
Gemcitabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Cytokine Release Syndrome
×
fludarabine
×
30 days
×
Clear all
No trials found.